|
ROD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.855600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.775600E-03 |
| Normal-vs-Stage2 |
4.729600E-02 |
| Normal-vs-Stage3 |
7.516400E-03 |
| Normal-vs-Stage4 |
2.40969999999452E-05 |
| Stage1-vs-Stage2 |
9.660000E-01 |
| Stage1-vs-Stage3 |
8.457400E-01 |
| Stage1-vs-Stage4 |
2.459900E-02 |
| Stage2-vs-Stage3 |
8.747400E-01 |
| Stage2-vs-Stage4 |
1.369430E-01 |
| Stage3-vs-Stage4 |
8.995800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.742100E-03 |
| Normal-vs-AfricanAmerican |
3.272400E-02 |
| Normal-vs-Asian |
1.194370E-04 |
| Caucasian-vs-AfricanAmerican |
8.598600E-01 |
| Caucasian-vs-Asian |
5.166300E-02 |
| AfricanAmerican-vs-Asian |
2.662400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.738300E-03 |
| Normal-vs-Female |
3.837000E-03 |
| Male-vs-Female |
8.102400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.922200E-03 |
| Normal-vs-Age(41-60Yrs) |
8.212800E-04 |
| Normal-vs-Age(61-80Yrs) |
4.020700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.155200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.855800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.515600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.692000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.765400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.112400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.457000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.566000E-01 |
| Classical-VS-Follicular |
6.901000E-01 |
| Classical-VS-Other |
1.742010E-01 |
| Classical-VS-Normal |
4.282800E-03 |
| Tall-VS-Follicular |
4.518400E-01 |
| Tall-VS-Other |
1.253210E-01 |
| Tall-VS-Normal |
2.006400E-01 |
| Follicular-VS-Other |
1.062440E-01 |
| Follicular-VS-Normal |
1.197730E-02 |
| Other-VS-Normal |
8.504500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.608400E-04 |
| Normal-vs-N1 |
8.0735000000054E-05 |
| N0-vs-N1 |
2.405800E-01 |
|
|
